BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24639284)

  • 1. The clinical pathological features, diagnosis, treatment and prognosis of small intestine primary malignant tumors.
    Guo X; Mao Z; Su D; Jiang Z; Bai L
    Med Oncol; 2014 Apr; 31(4):913. PubMed ID: 24639284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors and treatment outcomes in patients with non-ampullary small bowel adenocarcinoma: Long-term analysis.
    Tian J; Liu J; Guo C; Yang X; Yang Y; Gou H; Qiu M; Cao D
    Medicine (Baltimore); 2019 Apr; 98(17):e15381. PubMed ID: 31027129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgically treated primary malignant tumor of small bowel: a clinical analysis.
    Han SL; Cheng J; Zhou HZ; Guo SC; Jia ZR; Wang PF
    World J Gastroenterol; 2010 Mar; 16(12):1527-32. PubMed ID: 20333796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathological characteristics and prognosis of patients with small bowel tumors: A single center analysis of 220 cases].
    Liao XL; Zhu YF; Zhang WH; Chen XL; Liu K; Zhao LY; Yang K; Hu JK
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):467-474. PubMed ID: 37217355
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection.
    Aydin D; Sendur MA; Kefeli U; Unal OU; Tastekin D; Akyol M; Tanrikulu E; Ciltas A; Ustaalioglu BB; Uysal M; Esbag O; Yazilitas D; Tanrıverdi O; Bilici A; Arpaci E; Berk V; Yetisyigit T; Ozdemir NY; Oztop I; Alacacioglu A; Aydin O; Ozcelik M; Yildirim E; Dinc N; Gumus M
    Clin Colorectal Cancer; 2017 Sep; 16(3):220-227. PubMed ID: 27670893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small bowel adenocarcinoma as a complication of celiac disease: clinical and diagnostic features.
    Caio G; Volta U; Ursini F; Manfredini R; De Giorgio R
    BMC Gastroenterol; 2019 Mar; 19(1):45. PubMed ID: 30917787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of surgery and chemotherapy for stage IV small bowel adenocarcinoma: A population-based analysis using Surveillance, Epidemiology, and End Result Program database.
    Liu T; Wu Y; Jiang T
    Cancer Med; 2020 Sep; 9(18):6638-6645. PubMed ID: 32750232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small Bowel Adenocarcinoma: 10-Year Experience in a Cancer Center-The Ottawa Hospital (TOH).
    Alfagih A; Alrehaili M; Asmis T
    Curr Oncol; 2022 Oct; 29(10):7439-7449. PubMed ID: 36290862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological features and treatment outcomes of metastatic or locally unresectable small bowel adenocarcinoma.
    Li X; Ying H; Cheng Y; Zhao L; Zhao S; Bai C; Zhou J
    J BUON; 2019; 24(6):2539-2545. PubMed ID: 31983130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma.
    Overman MJ; Kopetz S; Wen S; Hoff PM; Fogelman D; Morris J; Abbruzzese JL; Ajani JA; Wolff RA
    Cancer; 2008 Oct; 113(8):2038-45. PubMed ID: 18759326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history and prognostic factors for localised small bowel adenocarcinoma.
    Colina A; Hwang H; Wang H; Katz MHG; Sun R; Lee JE; Thomas J; Tzeng CW; Wolff RA; Raghav K; Overman MJ
    ESMO Open; 2020 Nov; 5(6):e000960. PubMed ID: 33188051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticators.
    Moon YW; Rha SY; Shin SJ; Chang H; Shim HS; Roh JK
    J Cancer Res Clin Oncol; 2010 Mar; 136(3):387-94. PubMed ID: 19760196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients.
    Dabaja BS; Suki D; Pro B; Bonnen M; Ajani J
    Cancer; 2004 Aug; 101(3):518-26. PubMed ID: 15274064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of small bowel tumors diagnosed by double-balloon endoscopy: Experience from a Chinese tertiary hospital.
    Zhang C; Hong L; Zhang T; Sun P; Sun J; Zhou J; Wang L; Fan R; Wang Z; Cheng S; Zhong J
    Turk J Gastroenterol; 2020 Jan; 31(1):30-35. PubMed ID: 32009611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcomes of Small Bowel Adenocarcinoma.
    Akce M; Jiang R; Zakka K; Wu C; Alese OB; Shaib WL; Behera M; El-Rayes BF
    Clin Colorectal Cancer; 2019 Dec; 18(4):257-268. PubMed ID: 31606297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single-center, open-label, phase 2 study.
    Gulhati P; Raghav K; Shroff RT; Varadhachary GR; Kopetz S; Javle M; Qiao W; Wang H; Morris J; Wolff RA; Overman MJ
    Cancer; 2017 May; 123(6):1011-1017. PubMed ID: 27859010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-balloon enteroscopy in small bowel tumors: a Chinese single-center study.
    Chen WG; Shan GD; Zhang H; Li L; Yue M; Xiang Z; Cheng Y; Wu CJ; Fang Y; Chen LH
    World J Gastroenterol; 2013 Jun; 19(23):3665-71. PubMed ID: 23801870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological features, surgical treatments, and survival outcomes of patients with small bowel adenocarcinoma.
    Zhang S; Yuan W; Zhang J; Chen Y; Zheng C; Ma J; Jiang Q; Zhao Y; Xu Q; Wang C
    Medicine (Baltimore); 2017 Aug; 96(31):e7713. PubMed ID: 28767610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and prognosis of malignant small bowel tumors: Experience from a university hospital in Chile.
    Silva F; Bustamante M; Latorre G; Flandez J; Montero I; Dukes E; Gandara V; Robles C; Uribe J; Iglesias A; Bellolio F; Molina ME; Migueles R; Urrejola G; Larach T; Besser N; Sharp A; Agüero C; Riquelme A; Vargas JI; Candia R; Monrroy H; De Simone F; Espino A
    Gastroenterol Hepatol; 2024 May; 47(5):491-499. PubMed ID: 38331316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suggestion of added value by bevacizumab to chemotherapy in patients with unresectable or recurrent small bowel cancer.
    Takayoshi K; Kusaba H; Uenomachi M; Mitsugi K; Makiyama C; Makiyama A; Uchino K; Shirakawa T; Shibata Y; Shinohara Y; Inadomi K; Tsuchihashi K; Arita S; Ariyama H; Esaki T; Akashi K; Baba E
    Cancer Chemother Pharmacol; 2017 Aug; 80(2):333-342. PubMed ID: 28653251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.